{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:03:24Z","timestamp":1774451004695,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00403-018-1875-z","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T09:01:02Z","timestamp":1540976462000},"page":"19-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Mortality and risk factors among Israeli bullous pemphigoid patients"],"prefix":"10.1007","volume":"311","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5829-5871","authenticated-orcid":false,"given":"Mati","family":"Rozenblat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awad","family":"Halaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tal","family":"Rozenblat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shani","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Sah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roni P.","family":"Dodiuk-Gad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ziv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,31]]},"reference":[{"issue":"3","key":"1875_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/jid.2010.301","volume":"131","author":"S Bastuji-Garin","year":"2011","unstructured":"Bastuji-Garin S, Joly P, Lemordant P, Sparsa A, Bedane C, Delaporte E, Roujeau JC, Bernard P, Guillaume JC, Ingen-Housz-Oro S, Maillard H (2011) Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol 131(3):637\u2013643","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1875_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","volume":"131","author":"P Bernard","year":"1995","unstructured":"Bernard P, Vaillant L, Labeille B, Bedane C, Arbeille B, Denoeux JP, Lorette G, Bonnetblanc JM, Prost C (1995) Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous diseases French study group. Arch Dermatol 131(1):48\u201352","journal-title":"Arch Dermatol"},{"issue":"6","key":"1875_CR3","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jaad.2014.07.052","volume":"71","author":"KE Brick","year":"2014","unstructured":"Brick KE, Weaver CH, Savica R, Lohse CM, Pittelkow MR, Boeve BF, Gibson LE, Camilleri MJ, Wieland CN (2014) A population-based study of the association between bullous pemphigoid and neurologic disorders. J Am Acad Dermatol 71(6):1191\u20131197","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1875_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jaad.2014.02.030","volume":"71","author":"KE Brick","year":"2014","unstructured":"Brick KE, Weaver CH, Lohse CM, Pittelkow MR, Lehman JS, Camilleri MJ, Al-Hashimi M, Wieland CN (2014) Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009. J Am Acad Dermatol 71(1):92\u201399","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1875_CR5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1006\/geno.1995.9936","volume":"29","author":"A Brown","year":"1995","unstructured":"Brown A, Dalp\u00e9 G, Mathieu M, Kothary R (1995) Cloning and characterization of the neural isoforms of human dystonin. Genomics 29(3):777\u2013780","journal-title":"Genomics"},{"issue":"3","key":"1875_CR6","doi-asserted-by":"publisher","first-page":"xx","DOI":"10.1111\/j.0022-202X.2005.23677.x","volume":"124","author":"J-C Bystryn","year":"2005","unstructured":"Bystryn J-C, Rudolph JL (2005) Why Is the mortality of bullous pemphigoid greater in Europe than in the US? J Invest Dermatol 124(3):xx\u2013xxi","journal-title":"J Invest Dermatol"},{"issue":"8","key":"1875_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1474-4422(17)30113-8","volume":"16","author":"D Chan","year":"2017","unstructured":"Chan D, Binks S, Nicholas JM, Frost C, Cardoso MJ, Ourselin S, Wilkie D, Nicholas R, Chataway J (2017) Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial. Lancet Neurol 16(8):591\u2013600","journal-title":"Lancet Neurol"},{"issue":"5","key":"1875_CR8","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/j.0022-202X.2004.22504.x","volume":"122","author":"RL Colbert","year":"2004","unstructured":"Colbert RL, Allen DM, Eastwood D, Fairley JA (2004) Mortality rate of bullous pemphigoid in a US medical center. J Invest Dermatol 122(5):1091\u20131095","journal-title":"J Invest Dermatol"},{"issue":"2","key":"1875_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1365-2133.2011.10413.x","volume":"165","author":"B Cort\u00e9s","year":"2011","unstructured":"Cort\u00e9s B, Marazza G, Naldi L, Comescure C, Borradori L, Autoimmune Bullous Disease Swiss Study Group (2011) Mortality of bullous pemphigoid in Switzerland: a prospective study. Br J Dermatol 165(2):368\u2013374","journal-title":"Br J Dermatol"},{"issue":"10","key":"1875_CR10","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/rheumatology\/kem186","volume":"46","author":"GA Ferreira","year":"2007","unstructured":"Ferreira GA, Navarro TP, Telles RW, Andrade LE, Sato EI (2007) Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial. Rheumatology 46(10):1560\u20131565","journal-title":"Rheumatology"},{"issue":"4","key":"1875_CR11","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/jdv.12065","volume":"28","author":"A Gual","year":"2012","unstructured":"Gual A, Mascar\u00f3 JM Jr, Rojas-Farreras S, Guilabert A, Juli\u00e0 M, Iranzo P (2012) Mortality of bullous pemphigoid in the first year after diagnosis: a retrospective study in a Spanish medical centre. J Eur Acad Dermatol Venereol 28(4):500\u2013506","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"1875_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa011592","volume":"346","author":"P Joly","year":"2002","unstructured":"Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E, Vaillant L, D\u2019Incan M, Plantin P, Bedane C, Young P, Bernard P, Bullous Diseases French Study Group (2002) A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 346(5):321\u2013327","journal-title":"N Engl J Med"},{"issue":"8","key":"1875_CR13","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/jid.2012.35","volume":"132","author":"P Joly","year":"2012","unstructured":"Joly P, Baricault S, Sparsa A, Bernard P, B\u00e9dane C, Duvert-Lehembre S, Courville P, Bravard P, R\u00e9mond B, Doffoel-Hantz V, B\u00e9nichou J (2012) Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol 132(8):1998\u20132004","journal-title":"J Invest Dermatol"},{"issue":"3","key":"1875_CR14","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/j.0022-202X.2005.23626.x","volume":"124","author":"P Joly","year":"2005","unstructured":"Joly P, Benichou J, Saiag P, Bernard P, Roujheu JC (2005) Response to: mortality rate of bullous pemphigoid in a US medical center. J Invest Dermatol 124(3):664\u2013665","journal-title":"J Invest Dermatol"},{"issue":"2 Pt 1","key":"1875_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","volume":"41","author":"M Jung","year":"1999","unstructured":"Jung M, Kippes W, Messer G, Zillikens D, Rzany B (1999) Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence. J Am Acad Dermatol 41(2 Pt 1):266\u2013268","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"1875_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00403-017-1772-x","volume":"309","author":"A Kalinska-Bienias","year":"2017","unstructured":"Kalinska-Bienias A, Lukowska-Smorawska K, Jagielski P, Kowalewski C, Rozniak K (2017) Mortality in bullous pemphigoid and prognostic factors in 1st and 3rd year of follow-up in specialized centre in Poland. Arch Dermatol Res 309(9):709\u2013719","journal-title":"Arch Dermatol Res"},{"issue":"8","key":"1875_CR17","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.bbmt.2017.04.009","volume":"23","author":"AS Kanate","year":"2017","unstructured":"Kanate AS, Hari PN, Pasquini MC, Visotcky A, Ahn KW, Boyd J, Guru Murthy GS, Rizzo JD, Saber W, Drobyski W, Michaelis L, Atallah E, Carlson KS, D\u2019Souza A, Fenske TS, Cumpston A, Bunner P, Craig M, Horowitz MM, Hmadani M (2017) Recipient immune modulation with atorvastatin for acute graft-versus-host disease prophylaxis after allogeneic transplantation. Biol Blood Marrow Transpl 23(8):1295\u20131302","journal-title":"Biol Blood Marrow Transpl"},{"issue":"1","key":"1875_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/ijd.13813","volume":"57","author":"K Kridin","year":"2018","unstructured":"Kridin K, Bergman R (2018) Ethnic variations in the epidemiology of bullous pemphigoid in Israel. Int J Dermatol 57(1):34\u201339","journal-title":"Int J Dermatol"},{"issue":"4","key":"1875_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jaad.2014.05.006","volume":"71","author":"JH Lee","year":"2014","unstructured":"Lee JH, Kim S-C (2014) Mortality of patients with bullous pemphigoid in Korea. J Am Acad Dermatol 71(4):676\u2013683","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1875_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1001\/archdermatol.2012.2994","volume":"149","author":"J Li","year":"2013","unstructured":"Li J, Zuo YG, Zheng HY (2013) Mortality of bullous pemphigoid in China. JAMA Dermatol 149(1):106\u2013108","journal-title":"JAMA Dermatol"},{"issue":"5","key":"1875_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00403-017-1736-1","volume":"309","author":"YD Liu","year":"2017","unstructured":"Liu YD, Wang YH, Ye YC, Zhao WL, Li L (2017) Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis. Arch Dermatol Res 309(5):335\u2013347","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"1875_CR22","first-page":"OC32","volume":"10","author":"K Mowla","year":"2016","unstructured":"Mowla K, Rajai E, Ghorbani A, Dargahi-Malamir M, Bahadoram M, Mohammadi S (2016) Effect of atorvastatin on the disease activity and severity of rheumatoid arthritis: double-blind randomized controlled trial. J Clin Diagn Res 10(5):OC32\u2013OC36","journal-title":"J Clin Diagn Res"},{"issue":"4","key":"1875_CR23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jaad.2008.07.022","volume":"59","author":"SR Parker","year":"2008","unstructured":"Parker SR, Dyson S, Brisman S, Pennie M, Swerlick RA, Khan R, Manos S, Korman BD, Xia Z, Korman NJ (2008) Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States. J Am Acad Dermatol 59(4):582\u2013588","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"1875_CR24","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/archdermatol.2009.205","volume":"145","author":"J Risser","year":"2009","unstructured":"Risser J, Lewis K, Weinstock MA (2009) Mortality of bullous skin disorders from 1979 through 2002 in the United States. Arch Dermatol 145(9):1005\u20131008","journal-title":"Arch Dermatol"},{"issue":"4","key":"1875_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/archderm.134.4.465","volume":"134","author":"JC Roujeau","year":"1998","unstructured":"Roujeau JC, Lok C, Bastuji-Garin S, Mhalla S, Enginger V, Bernard P (1998) High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol 134(4):465\u2013469","journal-title":"Arch Dermatol"},{"issue":"7","key":"1875_CR26","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1001\/archderm.138.7.903","volume":"138","author":"B Rzany","year":"2002","unstructured":"Rzany B, Partscht K, Jung M, Kippes W, Mecking D, Baima B, Prudio CM, Pawelczyk B, Messmer EM, Schuhmann M, Sinkgraven R et al (2002) Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age. Arch Dermatol 138(7):903\u2013908","journal-title":"Arch Dermatol"},{"key":"1875_CR27","unstructured":"The Central Bureau of Statistics (Israel) (2018) \n                    http:\/\/www.cbs.gov.il\/reader\/?MIval=cw_usr_view_SHTML&ID=705\n                    \n                  . Accessed 24 Jan 2018"},{"issue":"9","key":"1875_CR28","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1001\/archderm.134.9.1075","volume":"134","author":"L Vaillant","year":"1998","unstructured":"Vaillant L, Bernard P, Joly P, Prost C, Labeille B, Bedane C, Arbeille B, thomine E, Bertrand P, Lok C, Roujeau JC (1998) Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French bullous study group. Arch Dermatol 134(9):1075\u20131080","journal-title":"Arch Dermatol"},{"issue":"1","key":"1875_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/imm.12902","volume":"154","author":"R Zeiser","year":"2018","unstructured":"Zeiser R (2018) Immune modulatory effects of statins. Immunology 154(1):69\u201375","journal-title":"Immunology"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-018-1875-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-018-1875-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-018-1875-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,19]],"date-time":"2020-01-19T00:01:57Z","timestamp":1579392117000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-018-1875-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,31]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["1875"],"URL":"https:\/\/doi.org\/10.1007\/s00403-018-1875-z","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,31]]},"assertion":[{"value":"20 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author(s) declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Reviewed and approved by Emek Medical Center IRB (institutional review board), approval number: 151-15.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}